68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series.

Purpose: Currently, approximately 11–38% of prostate cancer (PCa) patients undergoing radical prostatectomy have a positive surgical margin (PSM) on histopathology. Cerenkov luminescence imaging (CLI) using 68Ga-prostate-specific membrane antigen (68Ga-PSMA) is a novel technique for intraoperative m...

Full description

Bibliographic Details

Published in:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 47; no. 11; pp. 2624 - 2633
Main Authors:	olde Heuvel, Judith, de Wit-van der Veen, Berlinda J., van der Poel, Henk G., Bekers, Elise M., Grootendorst, Maarten R., Vyas, Kunal N., Slump, Cornelis H., Stokkel, Marcel P. M.
Format:	Journal Article
Published:	Springer Nature Oct2020
Online Access:	View this record in EBSCOhost